Thyme Care Secures $95M Series C Funding to Drive Accessibility and Affordability in Cancer Care
Thyme Care, a trailblazer in value-based cancer care solutions, has successfully closed a $95 million Series C funding round, marking a significant milestone in its mission to revolutionize cancer care accessibility and affordability. This financing, comprising $55 million in equity from new investor Concord Health Partners and existing supporters like CVS Health® Ventures, Town Hall…